Recombinant Factor VIII Market Report

Global and Region Recombinant Factor VIII Market Demand & Opportunity Outlook 2022-2028

  • POSTDATE：Aug 02, 2022
  • PAGES：162
  • REPORT CODE：GMM993815
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • The report details the trend, potential and market size of Recombinant Factor VIII market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.

    The first part (Chapter1-7) mainly covers the qualitative analysis of Recombinant Factor VIIImarket, defines the market attractiveness level of Recombinant Factor VIII market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.

    The second part (Chapter8-12), based on the segmentation of Recombinant Factor VIII industry, describes the types of Recombinant Factor VIII market, the applications of major players and the market size, and deeply analyzes the current situation of the global Recombinant Factor VIII market and the development prospects and opportunities of Recombinant Factor VIII industry.

    The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.

    As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Recombinant Factor VIII market in Chapter 13.

    By Player:

    • Shire (Baxter)

    • CSL

    • Octapharma

    • Bayer

    • NovoNordisk

    • Pfizer

    • Biogen

    By Type:

    • 200IU

    • 250IU

    By End-User:

    • Hospital

    • Pharmacy

    By Geography:

    • United States

    • Europe

    • China

    • Japan

    • India

    • South Korea

  • TABLE OF CONTENT

    1 Introduction

    • 1.1 Market Definition

    • 1.2 Market Segment Analysis

    • 1.3 Market Size 2022

    • 1.4 Recombinant Factor VIII Market Outlook: Forecast for 2022 - 2028

    • 1.5 Pricing Analysis

    2 Executive Summary

    3 Recombinant Factor VIII Market Lineage Outlook

    • 3.1 Parent Market Outlook

    • 3.2 Related/Ancillary Market Outlook

    • 3.3 Penetration & Growth Prospect Mapping, 2022

    4 Market Analysis Tools: Porter's Five Forces

    • 4.1 Supplier Power

    • 4.2 Buyer Power

    • 4.3 Substitution Threat

    • 4.4 Threat of New Entrants

    • 4.5 Competitive Rivalry

    5 Recombinant Factor VIII Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)

    • 5.1 Political/Legal Landscape

    • 5.2 Economic Landscape

    • 5.3 Social Landscape

    • 5.4 Technology Landscape

    6 Recombinant Factor VIII Market - Value Chain Analysis

    • 6.1 Industry's Value Chain Analysis

    • 6.2 Product Life Cycle

    • 6.3 User Perspective Analysis

    7 Region and Country-wise Recombinant Factor VIII Market Analysis and Outlook to 2022

    • 7.1 Global Recombinant Factor VIII Consumption (2017-2022)

    • 7.2 United States Recombinant Factor VIII Consumption (2017-2022)

    • 7.3 Europe Recombinant Factor VIII Consumption (2017-2022)

    • 7.4 China Recombinant Factor VIII Consumption (2017-2022)

    • 7.5 Japan Recombinant Factor VIII Consumption (2017-2022)

    • 7.6 India Recombinant Factor VIII Consumption (2017-2022)

    • 7.7 South Korea Recombinant Factor VIII Consumption (2017-2022)

    8 Region and Country-wise Recombinant Factor VIII Market Analysis and Outlook to 2028

    • 8.1 Global Recombinant Factor VIII Consumption Forecast (2022-2028)

    • 8.2 United States Recombinant Factor VIII Consumption Forecast (2022-2028)

    • 8.3 Europe Recombinant Factor VIII Consumption Forecast (2022-2028)

    • 8.4 China Recombinant Factor VIII Consumption Forecast (2022-2028)

    • 8.5 Japan Recombinant Factor VIII Consumption Forecast (2022-2028)

    • 8.6 India Recombinant Factor VIII Consumption Forecast (2022-2028)

    • 8.7 South Korea Recombinant Factor VIII Consumption Forecast (2022-2028)

    9 Global Recombinant Factor VIII Market Outlook by Types and Applications to 2022

    • 9.1 Global Recombinant Factor VIII Consumption and Growth Rate by Type (2017-2022)

      • 9.1.1 Global 200IU Consumption and Growth Rate (2017-2022)

      • 9.1.2 Global 250IU Consumption and Growth Rate (2017-2022)

    • 9.2 Global Recombinant Factor VIII Consumption and Growth Rate by Application (2017-2022)

      • 9.2.1 Global Hospital Consumption and Growth Rate (2017-2022)

      • 9.2.2 Global Pharmacy Consumption and Growth Rate (2017-2022)

    10 Global Recombinant Factor VIII Market Outlook by Types and Applications to 2028

    • 10.1 Global Recombinant Factor VIII Consumption Forecast and Growth Rate by Type (2022-2028)

      • 10.1.1 Global 200IU Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.2 Global 250IU Consumption Forecast and Growth Rate (2022-2028)

    • 10.2 Global Recombinant Factor VIII Consumption Forecast and Growth Rate by Application (2022-2028)

      • 10.2.1 Global Hospital Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.2 Global Pharmacy Consumption Forecast and Growth Rate (2022-2028)

    11 Global Recombinant Factor VIII Import and Export Analysis (Top 5 Countries)

    • 11.1 Global Recombinant Factor VIII Import by Region (Top 5 Countries) (2017-2028)

    • 11.2 Global Recombinant Factor VIII Export by Region (Top 5 Countries) (2017-2028)

    12 Coronavirus Disease (COVID-19) Impact

    • 12.1 Industry Impact Analysis

    • 12.2 Recombinant Factor VIII Market Outlook to 2028 - COVID-19 Affected Forecasts

    13 Competition Matrix

    • 13.1 Target Markets

    • 13.2 Comprehensive Analysis of Products in Competitive Markets

    14 Global Recombinant Factor VIII Market Competitive Analysis

    • 14.1 Shire (Baxter)

      • 14.1.1 Shire (Baxter) Company Details

      • 14.1.2 Shire (Baxter) Recombinant Factor VIII Sales, Price, Value and Gross Profit (2017-2022)

      • 14.1.3 Shire (Baxter) Recombinant Factor VIII Product and Service

    • 14.2 CSL

      • 14.2.1 CSL Company Details

      • 14.2.2 CSL Recombinant Factor VIII Sales, Price, Value and Gross Profit (2017-2022)

      • 14.2.3 CSL Recombinant Factor VIII Product and Service

    • 14.3 Octapharma

      • 14.3.1 Octapharma Company Details

      • 14.3.2 Octapharma Recombinant Factor VIII Sales, Price, Value and Gross Profit (2017-2022)

      • 14.3.3 Octapharma Recombinant Factor VIII Product and Service

    • 14.4 Bayer

      • 14.4.1 Bayer Company Details

      • 14.4.2 Bayer Recombinant Factor VIII Sales, Price, Value and Gross Profit (2017-2022)

      • 14.4.3 Bayer Recombinant Factor VIII Product and Service

    • 14.5 NovoNordisk

      • 14.5.1 NovoNordisk Company Details

      • 14.5.2 NovoNordisk Recombinant Factor VIII Sales, Price, Value and Gross Profit (2017-2022)

      • 14.5.3 NovoNordisk Recombinant Factor VIII Product and Service

    • 14.6 Pfizer

      • 14.6.1 Pfizer Company Details

      • 14.6.2 Pfizer Recombinant Factor VIII Sales, Price, Value and Gross Profit (2017-2022)

      • 14.6.3 Pfizer Recombinant Factor VIII Product and Service

    • 14.7 Biogen

      • 14.7.1 Biogen Company Details

      • 14.7.2 Biogen Recombinant Factor VIII Sales, Price, Value and Gross Profit (2017-2022)

      • 14.7.3 Biogen Recombinant Factor VIII Product and Service

    15 Appendix


    TABLE OF CHARTS

    • Table Definition of Recombinant Factor VIII

    • Figure Recombinant Factor VIII Picture

    • Table Global Recombinant Factor VIII Market Size and Forecast 2022 - 2028 (USD million)

    • Figure Global Recombinant Factor VIII Market Size and Forecast 2022 - 2028 (USD million)

    • Figure Global Recombinant Factor VIII Market: Year-over-year Growth 2022 - 2028 (%)

    • Table Parent Market Analysis

    • Figure Parent Market Price

    • Table Related/Ancillary Market Outlook Analysis

    • Table Supplier Power Analysis

    • Table Buyer Power Analysis

    • Table Substitution Threat Analysis

    • Table Threat of New Entrants Analysis

    • Table Competitive Rivalry Analysis

    • Figure Global Recombinant Factor VIII Consumption by Country (2017-2022)

    • Figure United States Recombinant Factor VIII Consumption and Growth Rate (2017-2022)

    • Table Europe Recombinant Factor VIII Consumption and Growth Rate (2017-2022)

    • Figure China Recombinant Factor VIII Consumption and Growth Rate (2017-2022)

    • Figure Japan Recombinant Factor VIII Consumption and Growth Rate (2017-2022)

    • Figure India Recombinant Factor VIII Consumption and Growth Rate (2017-2022)

    • Figure South Korea Recombinant Factor VIII Consumption and Growth Rate (2017-2022)

    • Figure Global Recombinant Factor VIII Consumption Forecast by Country (2022-2028)

    • Figure United States Recombinant Factor VIII Consumption Forecast and Growth Rate (2022-2028)

    • Table Europe Recombinant Factor VIII Consumption Forecast and Growth Rate (2022-2028)

    • Figure China Recombinant Factor VIII Consumption Forecast and Growth Rate (2022-2028)

    • Figure Japan Recombinant Factor VIII Consumption Forecast and Growth Rate (2022-2028)

    • Figure India Recombinant Factor VIII Consumption Forecast and Growth Rate (2022-2028)

    • Figure South Korea Recombinant Factor VIII Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global 200IU Consumption and Growth Rate (2017-2022)

    • Figure Global 250IU Consumption and Growth Rate (2017-2022)

    • Figure Global Hospital Consumption and Growth Rate (2017-2022)

    • Figure Global Pharmacy Consumption and Growth Rate (2017-2022)

    • Figure Global 200IU Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global 250IU Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Hospital Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Pharmacy Consumption Forecast and Growth Rate (2022-2028)

    • Table Global Recombinant Factor VIII Import by Region (Top 5 Countries) (2017-2028)

    • Table Global Recombinant Factor VIII Export by Region (Top 5 Countries) (2017-2028)

    • Table Shire (Baxter) (Foundation Year, Company Profile and etc.)

    • Table Shire (Baxter) Recombinant Factor VIII Sales, Price, Value and Gross Profit (2017-2022)

    • Table Shire (Baxter) Recombinant Factor VIII Product and Service

    • Table CSL (Foundation Year, Company Profile and etc.)

    • Table CSL Recombinant Factor VIII Sales, Price, Value and Gross Profit (2017-2022)

    • Table CSL Recombinant Factor VIII Product and Service

    • Table Octapharma (Foundation Year, Company Profile and etc.)

    • Table Octapharma Recombinant Factor VIII Sales, Price, Value and Gross Profit (2017-2022)

    • Table Octapharma Recombinant Factor VIII Product and Service

    • Table Bayer (Foundation Year, Company Profile and etc.)

    • Table Bayer Recombinant Factor VIII Sales, Price, Value and Gross Profit (2017-2022)

    • Table Bayer Recombinant Factor VIII Product and Service

    • Table NovoNordisk (Foundation Year, Company Profile and etc.)

    • Table NovoNordisk Recombinant Factor VIII Sales, Price, Value and Gross Profit (2017-2022)

    • Table NovoNordisk Recombinant Factor VIII Product and Service

    • Table Pfizer (Foundation Year, Company Profile and etc.)

    • Table Pfizer Recombinant Factor VIII Sales, Price, Value and Gross Profit (2017-2022)

    • Table Pfizer Recombinant Factor VIII Product and Service

    • Table Biogen (Foundation Year, Company Profile and etc.)

    • Table Biogen Recombinant Factor VIII Sales, Price, Value and Gross Profit (2017-2022)

    • Table Biogen Recombinant Factor VIII Product and Service


Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US